{
  "ptid_time": "127_S_5185_2015-06-02",
  "img_path": "/data/qiuhui/data/adni/images/127_S_5185/2015-06-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 27,913 mm³, 0.6% below the reference mean. With a Z-score of -0.01 (49.5th percentile), this represents normal volume ; hippocampal volume measures 7,367 mm³, 3.5% above the reference mean. With a Z-score of 0.33 (62.8th percentile), this represents normal volume ; whole brain volume measures 1,121,310 mm³, 15.0% above the reference mean. With a Z-score of 1.89 (97.1th percentile), this represents moderate enlargement; entorhinal cortex volume measures 4,174 mm³, 13.6% above the reference mean. With a Z-score of 0.84 (79.9th percentile), this represents normal volume ; fusiform gyrus volume measures 19,450 mm³, 14.3% above the reference mean. With a Z-score of 1.30 (90.4th percentile), this represents mild enlargement; middle temporal gyrus volume measures 20,125 mm³, 5.0% above the reference mean. With a Z-score of 0.43 (66.7th percentile), this represents normal volume . ",
  "text_data": "Age is 71.9 years. Gender is Female. Education: 20 years. MMSE: 30.0. MoCA: 28.0. Logical Memory: 19.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.27 SUVR (mild elevated); Amyloid beta: 595.70 pg/mL (mild reduced); Total tau: 478.90 pg/mL (profound elevated); Phosphorylated tau: 51.00 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements are largely within or above normal ranges, with no significant atrophy in key regions like the hippocampus or entorhinal cortex. However, the CSF biomarkers (Aβ mildly reduced, T-tau and P-tau profoundly elevated) and mild AV45 elevation suggest Alzheimer's pathology, despite normal cognitive scores (MMSE 30, MoCA 28).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology, given biomarker profile).  \n\n**Confidence:** **Medium** (cognitive scores are intact, but biomarkers strongly suggest early neurodegenerative changes).  \n\n*Note: The discrepancy between preserved brain volumes and abnormal biomarkers may indicate a very early stage of Alzheimer's continuum, warranting close monitoring.*",
  "timestamp": "2025-07-26T13:27:26.718180"
}